Autoimmune diseases affect millions of Americans and are chronic and often disabling illnesses with no cures. Current treatments help to prevent the symptoms of autoimmune disease, but there is a need for greater understanding of the underlying mechanisms of disease in order to facilitate improved treatments, and perhaps one day ? a cure. Current knowledge indicates that autoimmune disease arise due to a combination of genetic predispositions and environmental factors, but the etiology is not fully understood. We are studying one of the genetic factors that are implicated in human autoimmunity through both genome-wide association studies (GWAS) and recently identified patients with mutations in this gene. Using a newly established strain of mutant mice, we found a profound defect in immune tolerance, with high levels of autoreactive antibodies in the serum of very young mice. Antibodies are produced by B cells, and the presence of autoreactive antibodies indicates that this gene is necessary to control how B cells respond to antigen and to ensure tolerance to self. We propose to employ our mutant mice as a new model of autoimmunity to investigate the molecular mechanisms underlying the break of tolerance. We have preliminary data demonstrating lung infiltrates in this mouse models, and propose for the Fellowship candidate to investigate the cellular composition and subtype identity of the infiltrating cells. Furthermore, we have indications that gene isoform expression is important in the proper regulation of immune tolerance, and propose that the Fellowship candidate investigates the gene isoform expression across different stages of B-cell development. The work will be supplementing the work in the parental grant, and the candidate will be trained by current members of the laboratory research group.

Public Health Relevance

Autoimmune diseases can lead to chronic and often disabling illnesses, and is a major health problem in the US as it affects millions of Americans. While there are treatments available to help prevent the symptoms of autoimmune disease, there is no cure, and the available treatments do not work for all patients with autoimmune diseases. There is therefore an urgent need for greater understanding of the underlying mechanisms of disease in order to facilitate improved treatments, and perhaps one day ? a cure.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
3R01AI127709-02S1
Application #
9971329
Study Section
Program Officer
Peyman, John A
Project Start
2018-06-15
Project End
2023-05-31
Budget Start
2020-03-26
Budget End
2020-05-31
Support Year
2
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Pathology
Type
Schools of Medicine
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94118